Epoxyeicosatrienoic acids and heme oxygenase-1 interaction attenuates diabetes and metabolic syndrome complications

Prostaglandins and Other Lipid Mediators

Volumn 97, Issue 1-2, 2012, Pages 1-16

  Burgess, Angela ^a   Vanella, Luca ^a   Bellner, Lars ^b   Schwartzman, Michal L ^b   Abraham, Nader G ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Adipocyte; EET agonist; HO 1; MSC; pAKT

Indexed keywords

AKRI 2728; ANTILIPEMIC AGENT; CYTOKINE; EPOXYICOSATRIENOIC ACID; ERYTHROPOIETIN; HEME; HEME OXYGENASE 1; PEPTIDOMIMETIC AGENT; PROTEIN L 4F; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; BLOOD VESSEL REACTIVITY; CELL DIFFERENTIATION; HUMAN; INSULIN SENSITIVITY; MESENCHYMAL STEM CELL; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVIEW; STEM CELL; WEIGHT GAIN;

8,11,14-EICOSATRIENOIC ACID; ANIMALS; DIABETES COMPLICATIONS; HEME OXYGENASE-1; HUMANS; METABOLIC SYNDROME X; PROTEIN BINDING;

EID: 84855800976     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2011.10.002     Document Type: Review

References (156)

1. S.J. Peterson, G. Drummond, and D.H. Kim L-4F treatment reduces adiposity, increases adiponectin levels and improves insulin sensitivity in obese mice J Lipid Res 49 2008 1658 1669
2. S.J. Peterson, and W.H. Frishman Targeting heme oxygenase: therapeutic implications for diseases of the cardiovascular system Cardiol Rev 17 2009 99 111
3. M. Li, D.H. Kim, and P.L. Tsenovoy Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance Diabetes 57 2008 1526 1535
4. N.G. Abraham, and A. Kappas Pharmacological and clinical aspects of heme oxygenase Pharmacol Rev 60 2008 79 127 (Pubitemid 351439218)
5. N.G. Abraham, and A. Kappas Heme oxygenase and the cardiovascular-renal system Free Radic Biol Med 39 2005 1 25 (Pubitemid 40733115)
6. A.A. Spector, X. Fang, G.D. Snyder, and N.L. Weintraub Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function Prog Lipid Res 43 2004 55 90 (Pubitemid 37433867)
7. J.H. Capdevila, J.R. Falck, and J.D. Imig Roles of the cytochrome P450 arachidonic acid monooxygenases in the control of systemic blood pressure and experimental hypertension Kidney Int 72 2007 683 689 (Pubitemid 47373784)
8. J.D. Imig Eicosanoid regulation of the renal vasculature Am J Physiol Renal Physiol 279 2000 F965 F981
9. A.J. Friedenstein, U.F. Deriglasova, and N.N. Kulagina Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method Exp Hematol 2 1974 83 92
10. A. Brown, J.D. Lutton, J. Nelson, N.G. Abraham, and R.D. Levere Microenvironmental cytokines and expression of erythroid heme metabolic enzymes Blood Cells 13 1987 123 136 (Pubitemid 17127168)
11. J.L. Chertkov, S. Jiang, J.D. Lutton, R.D. Levere, and N.G. Abraham Hemin stimulation of hemopoiesis in murine long-term bone marrow culture Exp Hematol 19 1991 905 909
12. J.L. Chertkov, S. Jiang, and J.D. Lutton The hematopoietic stromal microenvironment promotes retrovirus-mediated gene transfer into hematopoietic stem cells Stem Cells 11 1993 218 227 (Pubitemid 23150941)
13. J.D. Lutton, R.D. Levere, and N.G. Abraham Physiologic role of heme and cytochrome P-450 in hematopoietic cells Proc Soc Exp Biol Med 196 1991 260 269
14. N.G. Abraham, J.L. Chertkov, and R. Staudinger Long-term bone marrow stromal and hemopoietic toxicity to AZT: protective role of heme and IL-1 Exp Hematol 21 1993 263 268 (Pubitemid 24216766)
15. A. Orlandi, E. Chavakis, F. Seeger, M. Tjwa, A.M. Zeiher, and S. Dimmeler Long-term diabetes impairs repopulation of hematopoietic progenitor cells and dysregulates the cytokine expression in the bone marrow microenvironment in mice Basic Res Cardiol 105 2010 703 712
16. O. Gurevitch, S. Khitrin, A. Valitov, and S. Slavin Osteoporosis of hematologic etiology Exp Hematol 35 2007 128 136 (Pubitemid 46014378)
17. Y. Ueda, M. Inaba, and K. Takada Induction of senile osteoporosis in normal mice by intra-bone marrow-bone marrow transplantation from osteoporosis-prone mice Stem Cells 25 2007 1356 1363 (Pubitemid 47106002)
18. E.M. Horwitz, B.K. Le, and M. Dominici Clarification of the nomenclature for MSC: the international society for cellular therapy position statement Cytotherapy 7 2005 393 395 (Pubitemid 41671625)
19. N.G. Abraham, R.D. Levere, and J.D. Lutton Eclectic mechanisms of heme regulation of hematopoiesis Int J Cell Cloning 9 1991 185 210
20. N.G. Abraham, M.L. Friedland, and R.D. Levere E. Brown, Progress in hematology 1983 Grune and Stratton New York 75 130
21. N.G. Abraham Molecular regulation - biological role of heme in hematopoiesis Blood Rev 5 1991 19 28
22. J. Harrison, A. Kappas, and R.D. Levere Additive effect of erythropoietin and heme on murine hematopoietic recovery after azidothymidine treatment Blood 82 1993 3574 3579 (Pubitemid 24006037)
23. A. Yachie, Y. Niida, and T. Wada Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency J Clin Invest 103 1999 129 135 (Pubitemid 29031171)
24. N.G. Abraham Hematopoietic effects of benzene inhalation assessed by long-term bone marrow culture Environ Health Perspect 104 Suppl. 6 1996 1277 1282 (Pubitemid 27046156)
25. N.G. Abraham, D. Bucher, and U. Niranjan Microenvironmental toxicity of azidothymidine: partial sparing with hemin Blood 74 1989 139 144 (Pubitemid 19187421)
26. P. Pratheeshkumar, and G. Kuttan Ameliorative action of Vernonia cinerea L. on cyclophosphamide-induced immunosuppression and oxidative stress in mice Inflammopharmacology 18 2010 197 207
27. K. Kemp, R. Morse, K. Sanders, J. Hows, and C. Donaldson Alkylating chemotherapeutic agents cyclophosphamide and melphalan cause functional injury to human bone marrow-derived mesenchymal stem cells Ann Hematol 2011
28. G. Loewy, P. Cook, and T. Ahmed Specificity of heme for hemopoietic recovery from AZT toxicity Hematol Pathol 6 1992 79 85
29. S. Chen, M.H. Kapturczak, and C. Wasserfall Interleukin 10 attenuates neointimal proliferation and inflammation in aortic allografts by a heme oxygenase-dependent pathway Proc Natl Acad Sci USA 102 2005 7251 7256 (Pubitemid 40696365)
30. Y. Drechsler, A. Dolganiuc, and O. Norkina Heme oxygenase-1 mediates the anti-inflammatory effects of acute alcohol on IL-10 induction involving p38 MAPK activation in monocytes J Immunol 177 2006 2592 2600 (Pubitemid 44201018)
31. J.L. da Silva, T. Morishita, and B. Escalante Dual role of heme oxygenase in epithelial cell injury: contrasting effects of short-term and long-term exposure to oxidant stress J Lab Clin Med 128 1996 290 296 (Pubitemid 27506940)
32. C.R. Bruce, A.L. Carey, J.A. Hawley, and M.A. Febbraio Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism Diabetes 52 2003 2338 2345 (Pubitemid 37059505)
33. W. Bao, F. Song, and X. Li Association between heme oxygenase-1 gene promoter polymorphisms and type 2 diabetes mellitus: a HuGE review and meta-analysis Am J Epidemiol 172 2010 631 636
34. N.G. Abraham, M. Li, L. Vanella, S.J. Peterson, S. Ikehara, and D. Asprinio Bone marrow stem cell transplant into intra-bone cavity prevents type 2 diabetes: role of heme oxygenase-adiponectin J Autoimmun 30 2008 128 135
35. S. Ikehara, M. Kawamura, and F. Takao Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells Proc Natl Acad Sci USA 87 1990 8341 8344
36. S. Ikehara, M. Inaba, and R. Yasumizu Autoimmune diseases as stem cell disorders Tohoku J Exp Med 173 1994 141 155
37. A.V. Vanikar, S.D. Dave, U.G. Thakkar, and H.L. Trivedi Cotransplantation of adipose tissue-derived insulin-secreting mesenchymal stem cells and hematopoietic stem cells: a novel therapy for insulin-dependent diabetes mellitus Stem Cells Int 2010 2010 582382
38. S. Ikehara, H. Ohtsuki, and R.A. Good Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation Proc Natl Acad Sci USA 82 1985 7743 7747 (Pubitemid 16204425)
39. S. Ikehara The future of stem cell transplantation in autoimmune disease Clin Rev Allergy Immunol 38 2010 292 297
40. S. Ikehara Autoimmune diseases as stem cell disorders: normal stem cell transplant for their treatment Int J Mol Med 1 1998 5 16 [review]
41. M. Li, N.G. Abraham, and L. Vanella Successful modulation of type 2 diabetes in db/db mice with intra-bone marrow-bone marrow transplantation plus concurrent thymic transplantation J Autoimmun 35 2010 414 423
42. K.E. Wellen, and G.S. Hotamisligil Inflammation, stress, and diabetes J Clin Invest 115 2005 1111 1119 (Pubitemid 40629025)
43. R. Robertson, H. Zhou, T. Zhang, and J.S. Harmon Chronic oxidative stress as a mechanism for glucose toxicity of the beta cell in type 2 diabetes Cell Biochem Biophys 48 2007 139 146 (Pubitemid 47340880)
44. V. Poitout, and R.P. Robertson Minireview: secondary beta-cell failure in type 2 diabetes - a convergence of glucotoxicity and lipotoxicity Endocrinology 143 2002 339 342 (Pubitemid 34107184)
45. J.L. Evans, I.D. Goldfine, B.A. Maddux, and G.M. Grodsky Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes Endocr Rev 23 2002 599 622 (Pubitemid 35191625)
46. A.L. Kruger, S.J. Peterson, and M.L. Schwartzman Up-regulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and antiapoptotic effects J Pharmacol Exp Ther 319 2006 1144 1152
47. G. Kronke, A. Kadl, and E. Ikonomu Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors Arterioscler Thromb Vasc Biol 27 2007 1276 1282 (Pubitemid 46809415)
48. S. Turkseven, A. Kruger, and C.J. Mingone Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes Am J Physiol Heart Circ Physiol 289 August (2) 2005 H701 H707
49. S. Turkseven, G. Drummond, and R. Rezzani Impact of silencing HO-2 on EC-SOD and the mitochondrial signaling pathway J Cell Biochem 100 2007 815 823
50. T. Morita Heme oxygenase atherosclerosis Arterioscler Thromb Vasc Biol 25 2005 1786 1795
51. R.J. Roman P-450 metabolites of arachidonic acid in the control of cardiovascular function Physiol Rev 82 2002 131 185 (Pubitemid 34654217)
52. M. Laniado-Schwartzman, and N.G. Abraham The renal cytochrome P-450 arachidonic acid system Pediatr Nephrol 6 1992 490 498
53. M.D. Maines, and A. Kappas Cobalt induction of hepatic heme oxygenase; with evidence that cytochrome P450 is not essential for this enzyme activity Proc Natl Acad Sci USA 71 1974 4293 4297
54. M. Schwartzman, N.R. Ferreri, M.A. Carroll, E. Songu-Mize, and J.C. McGiff Renal cytochrome P450-related arachidonate metabolite inhibits (Na+ + K+)ATPase Nature 314 1985 620 622 (Pubitemid 15080837)
55. M. Schwartzman, E. Liberman, and A. Raz Bradykinin and angiotensin II activation of arachidonic acid deacylation and prostaglandin E2 formation in rabbit kidney Hormone-sensitive versus hormone-insensitive lipid pools of arachidonic acid J Biol Chem 256 1981 2329 2333 (Pubitemid 11151491)
56. J.H. Capdevila, J.R. Falck, and R.W. Estabrook Cytochrome P450 and the arachidonate cascade FASEB J 6 1992 731 736
57. W.B. Campbell, and J.R. Falck Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors Hypertension 49 2007 590 596
58. D.C. Zeldin Epoxygenase pathways of arachidonic acid metabolism J Biol Chem 276 2001 36059 36062
59. P.E. Scarborough, J. Ma, W. Qu, and D.C. Zeldin P450 subfamily CYP2J and their role in the bioactivation of arachidonic acid in extrahepatic tissues Drug Metab Rev 31 1999 205 234 (Pubitemid 29106659)
60. T.C. Delozier, G.E. Kissling, and S.J. Coulter Detection of human CYP2C8 CYP2C9, and CYP2J2 in cardiovascular tissues Drug Metab Dispos 35 2007 682 688 (Pubitemid 46513273)
61. T.C. Delozier, C.C. Tsao, and S.J. Coulter CYP2C44, a new murine CYP2C that metabolizes arachidonic acid to unique stereospecific products J Pharmacol Exp Ther 310 2004 845 854 (Pubitemid 39108903)
62. M. Spiecker, H. Darius, and T. Hankeln Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2 Circulation 110 2004 2132 2136 (Pubitemid 39372490)
63. N.G. Abraham, E. Feldman, J.R. Falck, J.D. Lutton, and M.L. Schwartzman Modulation of erythropoiesis by novel human bone marrow cytochrome P450-dependent metabolites of arachidonic acid Blood 78 1991 1461 1466
64. M.L. Schwartzman, P. Martasek, and A.R. Rios Cytochrome P450-dependent arachidonic acid metabolism in human kidney Kidney Int 37 1990 94 99 (Pubitemid 20023772)
65. B.T. Larsen, D.D. Gutterman, and A. Sato Hydrogen peroxide inhibits cytochrome p450 epoxygenases: interaction between two endothelium-derived hyperpolarizing factors Circ Res 102 2008 59 67
66. M.H. Wang, A. Smith, and Y. Zhou Downregulation of renal CYP-derived eicosanoid synthesis in rats with diet-induced hypertension Hypertension 42 2003 594 599 (Pubitemid 37237359)
67. D. Dai, D.C. Zeldin, and J.A. Blaisdell Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid Pharmacogenetics 11 2001 597 607 (Pubitemid 32953585)
68. J.D. Imig, C. Dimitropoulou, D.S. Reddy, R.E. White, and J.R. Falck Afferent arteriolar dilation to 11,12-EET analogs involves PP2A activity and Ca2+-activated K+ Channels Microcirculation 15 2008 137 150 (Pubitemid 351228638)
69. X. Zhao, and J.D. Imig Kidney CYP450 enzymes: biological actions beyond drug metabolism Curr Drug Metab 4 2003 73 84 (Pubitemid 36131685)
70. K. Node, Y. Huo, and X. Ruan Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids Science 285 1999 1276 1279 (Pubitemid 29398616)
71. X. Zhao, A. Dey, and O.P. Romanko Decreased epoxygenase and increased epoxide hydrolase expression in the mesenteric artery of obese Zucker rats Am J Physiol Regul Integr Comp Physiol 288 2005 R188 R196
72. B.M. De Taeye, C. Morisseau, and J. Coyle Expression and regulation of soluble epoxide hydrolase in adipose tissue Obesity (Silver Spring) 18 3 2010 Mar 489 498
73. D.C. Zeldin, J. Foley, and J.E. Boyle Predominant expression of an arachidonate epoxygenase in islets of Langerhans cells in human and rat pancreas Endocrinology 138 1997 1338 1346 (Pubitemid 27089795)
74. J.R. Falck, S. Manna, J. Moltz, N. Chacos, and J. Capdevila Epoxyeicosatrienoic acids stimulate glucagon and insulin release from isolated rat pancreatic islets Biochem Biophys Res Commun 114 1983 743 749 (Pubitemid 13030721)
75. X. Fang, S. Hu, and B. Xu 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha Am J Physiol Heart Circ Physiol 290 2006 H55 H63
76. B.T. Larsen, W.B. Campbell, and D.D. Gutterman Beyond vasodilatation: non-vasomotor roles of epoxyeicosatrienoic acids in the cardiovascular system Trends Pharmacol Sci 28 2007 32 38 (Pubitemid 46038535)
77. N.G. Abraham, J. Dresner, and R.D. Levere Presence of drug-metabolizing enzymes in rat bone marrow Clin Pharmacol Ther 29 1981 253
78. M.E. Vazquez-Vela, N. Torres, and A.R. Tovar White adipose tissue as endocrine organ and its role in obesity Arch Med Res 39 2008 715 728
79. M.I. Lefterova, and M.A. Lazar New developments in adipogenesis Trends Endocrinol Metab 20 2009 107 114
80. E.D. Rosen, C.J. Walkey, P. Puigserver, and B.M. Spiegelman Transcriptional regulation of adipogenesis Genes Dev 14 2000 1293 1307 (Pubitemid 30397073)
81. F.M. Gregoire, C.M. Smas, and H.S. Sul Understanding adipocyte differentiation Physiol Rev 78 1998 783 809 (Pubitemid 28340604)
82. P. Tontonoz, E. Hu, and B.M. Spiegelman Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor Cell 79 December (7) 1994 1147 1156
83. S. Gesta, Y.H. Tseng, and C.R. Kahn Developmental origin of fat: tracking obesity to its source Cell 131 2007 242 256 (Pubitemid 47576146)
84. J.Y. Kim, W.E. van de, and M. Laplante Obesity-associated improvements in metabolic profile through expansion of adipose tissue J Clin Invest 117 2007 2621 2637 (Pubitemid 47494363)
85. R.M. Evans, G.D. Barish, and Y.X. Wang PPARs and the complex journey to obesity Nat Med 10 2004 355 361 (Pubitemid 38508511)
86. S.T. Bailey, and S. Ghosh 'PPAR'ting ways with inflammation Nat Immunol 6 2005 966 967
87. E.D. Rosen, and O.A. MacDougald Adipocyte differentiation from the inside out Nat Rev Mol Cell Biol 7 2006 885 896 (Pubitemid 44871415)
88. C.N. Martini, M.V. Plaza, and M.C. Vila PKA-dependent and independent cAMP signaling in 3T3-L1 fibroblasts differentiation Mol Cell Endocrinol 298 2009 42 47
89. M. Styner, B. Sen, Z. Xie, N. Case, and J. Rubin Indomethacin promotes adipogenesis of mesenchymal stem cells through a cyclooxygenase independent mechanism J Cell Biochem 111 2010 1042 1050
90. G.X. Shen Oxidative stress and diabetic cardiovascular disorders: roles of mitochondria and NADPH oxidase Can J Physiol Pharmacol 88 2010 241 248
91. B. Gustafson Adipose tissue inflammation and atherosclerosis J Atheroscler Thromb 2010
92. N. Ouchi, J.L. Parker, J.J. Lugus, and K. Walsh Adipokines in inflammation and metabolic disease Nat Rev Immunol 11 2011 85 97
93. A. L'Abbate, D. Neglia, and C. Vecoli Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats Am J Physiol Heart Circ Physiol 293 2007 H3532 H3541
94. S. Furukawa, T. Fujita, and M. Shimabukuro Increased oxidative stress in obesity and its impact on metabolic syndrome J Clin Invest 114 2004 1752 1761 (Pubitemid 40385531)
95. N. Abraham, P. Tsenovoy, J. McClung, and G. Drummond Heme oxygenase: a target gene for anti-diabetic and obsesity Curr Pharm Des 14 2008 412 421 (Pubitemid 351516846)
96. A. Nicolai, M. Li, and D.H. Kim Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats Hypertension 53 2009 508 515
97. S.J. Peterson, D.H. Kim, and M. Li The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice J Lipid Res 50 2009 1293 1304
98. A. Burgess, M. Li, and L. Vanella Adipocyte heme oxygenase-1 induction attenuates metabolic syndrome in both male and female obese mice Hypertension 56 2010 1124 1130
99. J.F. Ndisang Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity Mediators Inflamm 2010 2010 359732
100. M.A. Rupnick, D. Panigrahy, and C.Y. Zhang Adipose tissue mass can be regulated through the vasculature Proc Natl Acad Sci USA 99 2002 10730 10735
101. D.H. Kim, A.P. Burgess, and M. Li Heme oxygenase-mediated increases in adiponectin decrease fat content and inflammatory cytokines, tumor necrosis factor-alpha and interleukin-6 in Zucker rats and reduce adipogenesis in human mesenchymal stem cells J Pharmacol Exp Ther 325 2008 833 840 (Pubitemid 351724315)
102. N.L. Dzamko, and G.R. Steinberg AMPK-dependent hormonal regulation of whole-body energy metabolism Acta Physiol (Oxf) 196 2009 115 127
103. L.E. Otterbein, B.S. Zuckerbraun, and M. Haga Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury Nat Med 9 2003 183 190 (Pubitemid 36227720)
104. X. Zhang, P. Shan, and L.E. Otterbein Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen-activated protein kinase pathway and involves caspase 3 J Biol Chem 278 2003 1248 1258 (Pubitemid 36790808)
105. R. Stocker, and M.A. Perrella Heme oxygenase-1: a novel drug target for atherosclerotic diseases? Circulation 114 2006 2178 2189 (Pubitemid 44747899)
106. J.F. Ndisang, and A. Jadhav Up-regulating the hemeoxygenase system enhances insulin sensitivity and improves glucose metabolism in insulin-resistant diabetes in Goto-Kakizaki rats Endocrinology 150 2009 2627 2636
107. H. Kaneto, N. Katakami, M. Matsuhisa, and T.A. Matsuoka Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis Mediators Inflamm 2010 2010 453892
108. T. Kadowaki, T. Yamauchi, N. Kubota, K. Hara, K. Ueki, and K. Tobe Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome J Clin Invest 116 2006 1784 1792 (Pubitemid 44033298)
109. M. Li, S. Peterson, and D. Husney Interdiction of the diabetic state in NOD mice by sustained induction of heme oxygenase: possible role of carbon monoxide and bilirubin Antioxid Redox Signal 9 2007 855 863 (Pubitemid 46919588)
110. T. Yamauchi, J. Kamon, and H. Waki The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance J Biol Chem 276 2001 41245 41254
111. A. Zisman, O.D. Peroni, and E.D. Abel Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance Nat Med 6 2000 924 928 (Pubitemid 30644753)
112. J.F. Ndisang, W. Zhao, and R. Wang Selective regulation of blood pressure by heme oxygenase-1 in hypertension Hypertension 40 2002 315 321 (Pubitemid 35006717)
113. J. Cao, K. Inoue, X. Li, G. Drummond, and N.G. Abraham Physiological significance of heme oxygenase in hypertension Int J Biochem Cell Biol 41 2009 1025 1033
114. W. Durante Heme oxygenase-1 in growth control and its clinical application to vascular disease J Cell Physiol 195 2003 373 382 (Pubitemid 36529865)
115. J. Cao, K. Sodhi, and K. Inoue Lentiviral-human heme oxygenase targeting endothelium improved vascular function in angiotensin II animal model of hypertension Hum Gene Ther 22 2011 271 282
116. G.S. Marks, J.F. Brien, K. Nakatsu, and B.E. McLaughlin Does carbon monoxide have a physiological function? Trends Pharmacol Sci 12 1991 185 188
117. W.W. Wang, D.L. Smith, and S.D. Zucker Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats Hepatology 40 2004 424 433 (Pubitemid 39062860)
118. C.J. Mingone, S.A. Gupte, J.L. Chow, M. Ahmad, N.G. Abraham, and M.S. Wolin Protoporphyrin IX generation from delta-aminolevulinic acid elicits pulmonary artery relaxation and soluble guanylate cyclase activation Am J Physiol Lung Cell Mol Physiol 291 2006 L337 L344
119. R.F. Furchgott, and D. Jothianandan Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light Blood Vessels 28 1991 52 61
120. B.R. Imhoff, and J.M. Hansen Extracellular redox environments regulate adipocyte differentiation Differentiation 80 2010 31 39
121. D.H. Kim, L. Vanella, and K. Inoue EET-agonist regulates human mesenchymal stem cells-derived adipocytes through activation of HO-1-pAKT signaling and a decrease in PPARgamma Stem Cells Dev 2010
122. K. Sodhi, K. Inoue, and K. Gotlinger Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice J Pharmacol Exp Ther 331 2009 906 916
123. A.I. Goodman, P.N. Chander, and R. Rezzani Heme oxygenase-2 deficiency contributes to diabetes-mediated increase in superoxide anion and renal dysfunction J Am Soc Nephrol 17 2006 1073 1081
124. H. Farhangkhoee, Z.A. Khan, and S. Mukherjee Heme oxygenase in diabetes-induced oxidative stress in the heart J Mol Cell Cardiol 35 2003 1439 1448 (Pubitemid 37491187)
125. M.H. Ghattas, L.T. Chuang, A. Kappas, and N.G. Abraham Protective effect of HO-1 against oxidative stress in human hepatoma cell line (HepG2) is independent of telomerase enzyme activity Int J Biochem Cell Biol 34 2002 1619 1628
126. N. Ishizaka, H. De Leon, and J.B. Laursen Angiotensin II-induced hypertension increases heme oxygenase-1 expression in rat aorta Circulation 96 1997 1923 1929 (Pubitemid 27400754)
127. R.A. Johnson, M. Lavesa, B. Askari, N.G. Abraham, and A. Nasjletti A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats Hypertension 25 1995 166 169
128. L.E. Otterbein, F.H. Bach, and J. Alam Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway Nat Med 6 2000 422 428 (Pubitemid 30208159)
129. A.A. Spector, and A.W. Norris Action of epoxyeicosatrienoic acids on cellular function Am J Physiol Cell Physiol 292 2007 C996 C1012
130. J.D. Imig Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases Am J Physiol Renal Physiol 289 2005 F496 F503
131. S. Norwood, J. Liao, B.D. Hammock, and G.Y. Yang Epoxyeicosatrienoic acids and soluble epoxide hydrolase: potential therapeutic targets for inflammation and its induced carcinogenesis Am J Transl Res 2 2010 447 457
132. D. Sacerdoti, C. Colombrita, and P.M. Di 11,12-Epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells Prostaglandins Other Lipid Mediat 82 2007 155 161 (Pubitemid 44880175)
133. T. Munzel, T. Gori, R.M. Bruno, and S. Taddei Is oxidative stress a therapeutic target in cardiovascular disease? Eur Heart J 31 2010 2741 2748
134. J.W. Baynes Role of oxidative stress in development of complications in diabetes Diabetes 40 1991 405 412
135. Y. Nakatani, H. Kaneto, and D. Kawamori Involvement of endoplasmic reticulum stress in insulin resistance and diabetes J Biol Chem 280 2005 847 851 (Pubitemid 40165054)
136. M. Lafontan, and J. Girard Impact of visceral adipose tissue on liver metabolism. Part I. Heterogeneity of adipose tissue and functional properties of visceral adipose tissue Diabetes Metab 34 2008 317 327
137. B.L. Wajchenberg Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome Endocr Rev 21 2000 697 738 (Pubitemid 32113289)
138. M. Bluher Adipose tissue dysfunction in obesity Exp Clin Endocrinol Diabetes 117 2009 241 250
139. H. Motoshima, X. Wu, and M.K. Sinha Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone J Clin Endocrinol Metab 87 2002 5662 5667 (Pubitemid 36034375)
140. A.A. Bulhak, C. Jung, C.G. Ostenson, J.O. Lundberg, P.O. Sjoquist, and J. Pernow PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway Am J Physiol Heart Circ Physiol 296 2009 H719 H727
141. Y. Fujio, T. Nguyen, D. Wencker, R.N. Kitsis, and K. Walsh Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart Circulation 101 2000 660 667 (Pubitemid 30094738)
142. R. Shibata, K. Sato, and D.R. Pimentel Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms Nat Med 11 2005 1096 1103 (Pubitemid 41486832)
143. M.T. Kearney, E.R. Duncan, M. Kahn, and S.B. Wheatcroft Insulin resistance and endothelial cell dysfunction: studies in mammalian models Exp Physiol 93 2008 158 163 (Pubitemid 350293975)
144. E. Duncan, P. Crossey, and S. Walker The effect of endothelium specific insulin resistance on endothelial function in vivo Diabetes 57 2008 3307 3314
145. I. Fleming, C. Schulz, B. Fichtlscherer, B.E. Kemp, B. Fisslthaler, and R. Busse AMP-activated protein kinase (AMPK) regulates the insulin-induced activation of the nitric oxide synthase in human platelets Thromb Haemost 90 2003 863 871 (Pubitemid 37427856)
146. S. Kovacic, C.L. Soltys, A.J. Barr, I. Shiojima, K. Walsh, and J.R. Dyck Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart J Biol Chem 278 2003 39422 39427 (Pubitemid 37248497)
147. S.L. Longnus, C. Segalen, J. Giudicelli, M.P. Sajan, R.V. Farese, and O.E. Van Insulin signalling downstream of protein kinase B is potentiated by 5'AMP-activated protein kinase in rat hearts in vivo Diabetologia 48 2005 2591 2601 (Pubitemid 41738227)
148. D.G. Hardie Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status Endocrinology 144 2003 5179 5183 (Pubitemid 37476044)
149. D.G. Hardie AMP-activated protein kinase as a drug target Annu Rev Pharmacol Toxicol 47 2007 185 210
150. M.A. Di Noia, D.S. Van, and F. Palmieri Heme oxygenase-1 enhances renal mitochondrial transport carriers and cytochrome C oxidase activity in experimental diabetes J Biol Chem 281 2006 15687 15693 (Pubitemid 43848455)
151. N. Ouchi, H. Kobayashi, and S. Kihara Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells J Biol Chem 279 2004 1304 1309 (Pubitemid 38082655)
152. J.F. Sun, T. Phung, and I. Shiojima Microvascular patterning is controlled by fine-tuning the Akt signal Proc Natl Acad Sci USA 102 2005 128 133 (Pubitemid 40094440)
153. E. Schulz, J. Dopheide, and S. Schuhmacher Suppression of the JNK pathway by induction of a metabolic stress response prevents vascular injury and dysfunction Circulation 118 2008 1347 1357
154. K. Chen, M.T. Kirber, H. Xiao, Y. Yang, and J.F. Keaney Jr. Regulation of ROS signal transduction by NADPH oxidase 4 localization J Cell Biol 181 2008 1129 1139 (Pubitemid 351915488)
155. J.M. Murabito, M.J. Keyes, and C.Y. Guo Cross-sectional relations of multiple inflammatory biomarkers to peripheral arterial disease: the Framingham Offspring Study Atherosclerosis 203 2008 509 514
156. N.G. Abraham, G.S. Drummond, J.D. Lutton, and A. Kappas The biological significance and physiological role of heme oxygenase Cell Physiol Biochem 6 1996 129 168 (Pubitemid 26252846)